C

CytoTools AG
XETRA:T5O

Watchlist Manager
CytoTools AG
XETRA:T5O
Watchlist
Price: 101.26 EUR 0.98%
Market Cap: 52.8m EUR
Have any thoughts about
CytoTools AG?
Write Note

CytoTools AG
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CytoTools AG
Other Operating Expenses Peer Comparison

Comparables:
BNTX
MOR
IMTX
BIO
FYB

Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
C
CytoTools AG
XETRA:T5O
Other Operating Expenses
-€694.3k
CAGR 3-Years
3%
CAGR 5-Years
-1%
CAGR 10-Years
-2%
BioNTech SE
NASDAQ:BNTX
Other Operating Expenses
€23.6m
CAGR 3-Years
-54%
CAGR 5-Years
36%
CAGR 10-Years
N/A
MorphoSys AG
XETRA:MOR
Other Operating Expenses
-€2m
CAGR 3-Years
67%
CAGR 5-Years
N/A
CAGR 10-Years
-24%
Immatics NV
NASDAQ:IMTX
Other Operating Expenses
€1.1m
CAGR 3-Years
56%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
Other Operating Expenses
€1.4m
CAGR 3-Years
N/A
CAGR 5-Years
-40%
CAGR 10-Years
-10%
Formycon AG
XETRA:FYB
Other Operating Expenses
€2.5m
CAGR 3-Years
360%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is CytoTools AG's Other Operating Expenses?
Other Operating Expenses
-694.3k EUR

Based on the financial report for Jun 30, 2023, CytoTools AG's Other Operating Expenses amounts to -694.3k EUR.

What is CytoTools AG's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 10Y
-2%

Over the last year, the Other Operating Expenses growth was 48%. The average annual Other Operating Expenses growth rates for CytoTools AG have been 3% over the past three years , -1% over the past five years , and -2% over the past ten years .

Back to Top